Showing posts with label Biopharmaceuticals. Show all posts
Showing posts with label Biopharmaceuticals. Show all posts
Wednesday, August 8, 2012

Chitosan-Based Systems for Biopharmaceuticals pdf

Chitosan-Based Systems for Biopharmaceuticals



Author:
Edition: 2
Publisher: Wiley
Binding: Hardcover
ISBN: 0470978325



Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics


Chitosan is a linear polysaccharide commercially produced by the deacetylation of chitin. Medical books Chitosan-Based Systems for Biopharmaceuticals. It is non-toxic, biodegradable, biocompatible, and acts as a bioadhesive with otherwise unstable biomolecules - making it a valuable component in the formulation of biopharmaceutical drugs.

Chitosan-Based Systems for Biopharmaceuticals provides an extensive overview of the application of chitosan and its derivatives in the development and optimisation of biopharmaceuticals. The book is divided in four different parts. Part I discusses general aspects of chitosan and its derivatives, with particular emphasis on issues related to the development of biopharmaceutical chitosan-based systems Medical books Chitosan-based Systems For Biopharmaceuticals: Delivery, Targeting And Polymer T. format hardback language english publication year 02 03 2012 subject mathematics sciences subject 2 chemistry title chitosan based systems for biopharmaceuticals delivery targeting and polymer therapeutics author sarmento bruno editor das neves jose editor publisher john wiley sons inc publication date mar 20 2012 pages 600 binding hardcover edition 2 nd dimensions 7 50 wx 9 50 hx 1 25 d isbn 0470978325 subject science chemistry organic description chitosan is a linear polysaccharide commercia

download button

Download link for Chitosan-based Systems For Biopharmaceuticals By Bruno Sarmento Hardcover Bo

format hardback language english publication year 02 03 2012 subject mathematics sciences subject 2 chemistry title chitosan based systems for biopharmaceuticals delivery targeting and polymer therapeutics author sarmento bruno editor das neves jose editor publisher john wiley sons inc publication date mar 20 2012 pages 600 binding hardcover edition 2 nd dimensions 7 50 wx 9 50 hx 1 25 d isbn 0470978325 subject science chemistry organic description chitosan is a linear polysaccharide commercia

Buy Chitosan-Based Systems for Biopharmaceuticals by and Read this Book on Kobo's Free Apps. Discover Kobo's Vast Collection of Ebooks Today - Over 3 Million Titles, Including 2 Million Free Ones!

Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics by Sarmento, Bruno/ Das Neves, Jose [Hardcover]

Chitosan is a linear polysaccharide commercially produced by the deacetylation of chitin. It is non-toxic, biodegradable, biocompatible, and acts as a bioadhesive with otherwise unstable biomolecules - making it a valuable component in the formulation of biopharmaceutical drugs.Chitosan-Based Systems for Biopharmaceuticals provides an extensive overview of the application of chitosan and its derivatives in the development and optimisation of biopharmaceuticals. The book is divided in four different parts. Part I discusses general aspects of chitosan and its derivatives, with particular emphasi



Medical Book Chitosan-Based Systems for Biopharmaceuticals



It is non-toxic, biodegradable, biocompatible, and acts as a bioadhesive with otherwise unstable biomolecules - making it a valuable component in the formulation of biopharmaceutical drugs.

Chitosan-Based Systems for Biopharmaceuticals provides an extensive overview of the application of chitosan and its derivatives in the development and optimisation of biopharmaceuticals. The book is divided in four different parts. Part I discusses general aspects of chitosan and its derivatives, with particular emphasis on issues related to the development of biopharmaceutical chitosan-based systems. Part II deals with the use of chitosan and derivatives in the formulation and delivery of biopharmaceuticals, and focuses on the synergistic effects between chitosan and this particular subset of pharmaceuticals. Part III discusses specific applications of chitosan and its derivatives for biopharmaceutical use. Finally, Part IV presents diverse viewpoints on different issues such as regulatory, manufacturing and toxicological requirements of chitosan and its derivatives related to the development of biopharmaceutical products, as well as their patent status, and clinical application and potential.

Topics covered include:

  • chemical and technological advances in chitins and chitosans useful for the formulation of biopharmaceuticals
  • physical properties of chitosan and derivatives in sol and gel states
  • absorption promotion properties of chitosan and derivatives
  • biocompatibility and biodegradation of chitosan and derivatives
  • biological and pharmacological activity of chitosan and derivatives
  • biological, chemical and physical compatibility of chitosan and biopharmaceuticals
  • approaches for functional modification or crosslinking of chitosan
  • use of chitosan and derivatives in conventional biopharmaceutical dosage forms
  • manufacture techniques of chitosan-based microparticles and nanoparticles for biopharmaceuticals
  • chitosan and derivatives for biopharmaceutical use: mucoadhesive properties
  • chitosan-based systems for mucosal delivery of biopharmaceuticals
  • chitosan-based delivery systems for mucosal vaccination
  • chitosan-based nanoparticulates for oral delivery of biopharmaceuticals
  • chitosan-based systems for ocular delivery of biopharmaceuticals
  • chemical modification of chitosan for delivery of DNA and siRNA
  • target-specific chitosan-based nanoparticle systems for nucleic acid delivery
  • functional PEGylated chitosan systems for biopharmaceuticals
  • stimuli-sensitive chitosan-based systems for biopharmaceuticals
  • chitosan copolymers for biopharmaceuticals
  • application of chitosan for anti-cancer biopharmaceutical delivery
  • chitosan-based biopharmaceuticals scaffolds in tissue engineering and regenerative medicine
  • wound healing properties of chitosan and its use in wound dressing biopharmaceuticals
  • toxicological properties of chitosan and derivatives for biopharmaceutical applications
  • regulatory status of chitosan and derivatives
  • patentability and intellectual property issues
  • quality control and good manufacturing practice
  • preclinical and clinical use of chitosan and derivatives for biopharmaceuticals

Chitosan-Based Systems for Biopharmaceuticals is an important compendium of fundamental concepts, practical tools and applications of chitosan-based biopharmaceuticals for researchers in academia and industry working in drug formulation and delivery, biopharmaceuticals, medicinal chemistry, pharmacy, bioengineering and new materials development.

download

Sunday, November 13, 2011

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals



Author: John Geigert
Edition: 2004
Publisher: Springer
Binding: Hardcover
ISBN: 0306480409



The Challenge of CMC Regulatory Compliance for Biopharmaceuticals


This book highlights the challenges facing quality assurance/quality control (QA/QC) in today's biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. Medical books The Challenge of CMC Regulatory Compliance for Biopharmaceuticals. Medical books The Challenge Of Cmc Regulatory Compliance For Biopharmaceuticals John Geigert. author john geigert format hardback language english publication year 01 12 2003 subject law subject 2 national law professional title the challenge of cmc regulatory compliance for biopharmaceuticals author john geigert publisher plenum pub corp publication date feb 01 2004 pages 350 binding hardcover edition 1 st dimensions 6 75 wx 9 75 hx 1 00 d isbn 0306480409 subject medical pharmacology brand new hardcover all orders get full access to our online status tracking service allowing you to v

download button

Download link for The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

author john geigert format hardback language english publication year 01 12 2003 subject law subject 2 national law professional title the challenge of cmc regulatory compliance for biopharmaceuticals author john geigert publisher plenum pub corp publication date feb 01 2004 pages 350 binding hardcover edition 1 st dimensions 6 75 wx 9 75 hx 1 00 d isbn 0306480409 subject medical pharmacology brand new hardcover all orders get full access to our online status tracking service allowing you to v

This book highlights the challenges facing quality assurance/quality control (QA/QC) in today's biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. It will put into perspective the need for a graded approach to QA/QC from early clinical trials through market approval. Since the first edition published in 2004, there have been more than 50 new regulatory guidances released by the Food and Drug Administration (FDA), European Medicines Agency (EMA) and ICH that affect the CMC regulatory compliance of b

This book highlights the challenges facing quality assurance/quality control (QA/QC) in today's biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. It will put into perspective the need for a graded approach to QA/QC from early clinical trials through market approval.

"This book highlights the challenges facing quality assurance/quality control (QA/QC) in today's biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. It will put into perspective the need for a graded approach to QA/QC from early clinical trials through market approval.File Size: 4086 KBPrint Length: 386 pagesPublisher: Springer; 1 edition (December 31, 2003) Sold by: Amazon Digital Services, Inc.Language: EnglishASIN: B001P05GXU"



Medical Book The Challenge of CMC Regulatory Compliance for Biopharmaceuticals



It will put into perspective the need for a graded approach to QA/QC from early clinical trials through market approval.

download